Drug Type Small molecule drug |
Synonyms AUR 108, AUR108 |
Target |
Mechanism DHODH inhibitors(Dihydroorotate dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lymphoma | Phase 1 | IN | 09 Aug 2023 | |
Lymphoma | Preclinical | US | 02 Dec 2020 |